Sungyoung Shin

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersMetabolic medicineProcess control and simulationInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 21, 2025
Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.

Xue Yang, Xiuquan Ma, Tianyue Zhao

|Aug 01, 2024
Integrative Modeling of Signaling Network Dynamics Identifies Cell Type-Selective Therapeutic Strategies for FGFR4-Driven Cancers.

Sung-Young Shin, Nicole J Chew, Milad Ghomlaghi

|Jan 25, 2024
Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.

Hon Yan Kelvin Yip, Sung-Young Shin, Annabel Chee

|Jan 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.

Xue Yang, Miguel I Cruz, Elizabeth V Nguyen

|Sep 16, 2021
Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.

Milad Ghomlaghi, Guang Yang, Sung-Young Shin

|Jul 02, 2021
Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network.

Milad Ghomlaghi, Anthony Hart, Nhan Hoang

Pageof 2

Frequent Collaborators

5 joint publications

Lan K Nguyen

3 joint publications

Roger J Daly

2 joint publications

Xue Yang

2 joint publications

Anderly C Chüeh